AI-programmable therapeutics via metagenomic foundation models for rare phage-mediated autoimmune modulations: early translational risks and benefits

Erum Habib, Izmal Urooj, Hamna Danyal Barry, Muhammad Awais, Muskan Kumari, Fatima Hajj

Open source

DOI
10.1097/ms9.0000000000005133
Published
2026-05-08
Container
Annals of Medicine & Surgery
Publisher
Ovid Technologies (Wolters Kluwer Health)
Open access
unknown

Credibility signals

uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1097/ms9.0000000000005133,
  title = {AI-programmable therapeutics via metagenomic foundation models for rare phage-mediated autoimmune modulations: early translational risks and benefits},
  author = {Erum Habib and Izmal Urooj and Hamna Danyal Barry and Muhammad Awais and Muskan Kumari and Fatima Hajj},
  year = {2026},
  journal = {Annals of Medicine \& Surgery},
  doi = {10.1097/ms9.0000000000005133},
  url = {https://doi.org/10.1097/ms9.0000000000005133}
}

RIS

TY  - JOUR
TI  - AI-programmable therapeutics via metagenomic foundation models for rare phage-mediated autoimmune modulations: early translational risks and benefits
AU  - Erum Habib
AU  - Izmal Urooj
AU  - Hamna Danyal Barry
AU  - Muhammad Awais
AU  - Muskan Kumari
AU  - Fatima Hajj
PY  - 2026
JO  - Annals of Medicine & Surgery
DO  - 10.1097/ms9.0000000000005133
UR  - https://doi.org/10.1097/ms9.0000000000005133
ER  - 

APA

Habib, E., Urooj, I., Barry, H. D., Awais, M., Kumari, M., & Hajj, F. (2026). AI-programmable therapeutics via metagenomic foundation models for rare phage-mediated autoimmune modulations: early translational risks and benefits. Annals of Medicine & Surgery. https://doi.org/10.1097/ms9.0000000000005133

Source records